Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer
Where
Beijing
Age
18 years and over
People
686
Run by
Luye Pharma Group Ltd.
See details and how to joinNCT06128837
Phase 2Not yet taking people in China
Myeloprotection With Trilaciclib in Pan-cancer Population
Where
Guangzhou
Age
18 years and over
People
132
Run by
Sun Yat-sen University
See details and how to joinNCT06297811
No phaseTaking people
Efficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery
Where
Guangzhou
Age
18 years to 75 years
People
20
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06286150
Phase 3Taking people
Effects of Digital Therapeutic in Whole Process Management of Lung Cancer
Where
Guangzhou
Age
18 years to 70 years
People
900
Run by
Sun Yat-sen University
See details and how to joinNCT06230445
Phase 2Taking people
AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer
Where
Zhengzhou
Age
18 years to 75 years
People
43
Run by
Henan Cancer Hospital
See details and how to joinNCT05377658
No phaseTaking people
Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer
Where
Shanghai
Age
18 years and over
People
377
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT05965024
No phaseTaking people
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
Where
Beijing
Age
18 years and over
People
60,000
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06255197
Phase 2Taking people
Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
Where
Jinan
Age
18 years to 75 years
People
30
Run by
Shandong Cancer Hospital and Institute
See details and how to joinNCT06241807
Phase 3Not yet taking people in China
A Study Of SY-3505 Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
Where
Beijing
Age
18 years and over
People
255
Run by
Shouyao Holdings (Beijing) Co. LTD
See details and how to joinNCT06254599
Phase 3Taking people
A Phase IIII Study of AL8326 in Small Cell Lung Cancer
Where
Changchun
Age
18 years and over
People
243
Run by
Advenchen Laboratories Nanjing Ltd.
See details and how to joinNCT06247605
Phase 1/2Taking people
WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases
Where
Shanghai
Age
18 years and over
People
56
Run by
Fudan University
See details and how to joinNCT06243003
Phase 2Not yet taking people in China
Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
Where
Wuhan, Zhengzhou
Age
18 years to 75 years
People
48
Run by
Henan Cancer Hospital
See details and how to joinNCT06236997
Phase 3Taking people
Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)
Where
Changsha, Shanghai
Age
18 years to 80 years
People
680
Run by
TYK Medicines, Inc
See details and how to joinNCT05382728
No phaseTaking people
Exploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world Study
Where
Shanghai
Age
18 years and over
People
2,000
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06216782
Phase 2Taking people
Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC
Where
Guangzhou
Age
18 years to 75 years
People
30
Run by
Sun Yat-sen University
See details and how to joinNCT05011487
No phaseTaking people
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
Where
Nanjing
Age
18 years and over
People
60
Run by
Jiangsu Cancer Institute & Hospital
See details and how to joinNCT06198868
Phase 2Not yet taking people in China
Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)
Where
Beijing
Age
18 years to 75 years
People
69
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06198907
No phaseTaking people
Non-risk Based Lang Cancer Screening With a One-off LDCT
Where
Guangzhou
Age
40 years to 74 years
People
11,000
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT04938804
Phase 2Taking people
To Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy
Where
Chengdu
Age
18 years and over
People
20
Run by
Juan LI, MD
See details and how to joinNCT06192849
Phase 2Not yet taking people in China
CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency
Where
Beijing
Age
18 years to 75 years
People
98
Run by
Convalife (Shanghai) Co., Ltd.
See details and how to joinNCT06183736
Phase 2Not yet taking people in China
Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer
Where
Shanghai
Age
18 years and over
People
160
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06109402
Phase 3Taking people
Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)
Where
Shanghai
Age
18 years to 80 years
People
390
Run by
Fudan University
See details and how to joinNCT06031181
No phaseTaking people
COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
Where
Beijing
Age
18 years and over
People
1,224
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06168032
No phaseTaking people
Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer
Where
Shanghai
Age
18 years and over
People
110
Run by
Hangzhou Broncus Medical Co., Ltd.
See details and how to joinNCT06052098
Phase 2Taking people
A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
Where
Shanghai
Age
18 years and over
People
62
Run by
Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT06147570